Figures
![Figure 1.](/tables/cr1523-g001.jpg)
Figure 1. PRISMA flow chart.
![Figure 2.](/tables/cr1523-g002.jpg)
Figure 2. Funnel plot of comparison: 9 HR for extended MACE revised, outcome: 9.1 HR for extended MACE. HR: hazard ratio; MACE: major adverse cardiac event.
![Figure 3.](/tables/cr1523-g003.jpg)
Figure 3. HR of MACE of GLP-1 RA versus comparators. GLA: glargine; GLIM: glimepiride; GLP-1 RA: glucagon-like peptide 1 receptor agonist; HR: hazard ratio; LIR: liraglutide; MACE: major adverse cardiac event; SIT: sitagliptin.
![Figure 4.](/tables/cr1523-g004.jpg)
Figure 4. HR of extended MACE of GLP-1 RA versus comparators. GLP-1 RA: glucagon-like peptide 1 receptor agonist; HR: hazard ratio; MACE: major adverse cardiac event.
![Figure 5.](/tables/cr1523-g005.jpg)
Figure 5. HR of all CV evets of GLP-1 RA versus comparators. CV: cardiovascular; GLA: glargine; GLIM: glimepiride; GLP-1 RA: glucagon-like peptide 1 receptor agonist; HR: hazard ratio; LIR: liraglutide; SIT: sitagliptin.
![Figure 6.](/tables/cr1523-g006.jpg)
Figure 6. HR of HF of GLP-1 RA versus comparators including hospitalization for HF (upper half) and occurrence of HF (lower half). CV: cardiovascular; GLA: glargine; GLIM: glimepiride; GLP-1 RA: glucagon-like peptide 1 receptor agonist; HR: hazard ratio; LIR: liraglutide; SIT: sitagliptin.
![Figure 7.](/tables/cr1523-g007.jpg)
Figure 7. HR of stroke of GLP-1 RA versus comparators. GLP-1 RA: glucagon-like peptide 1 receptor agonist; HR: hazard ratio.
![Figure 8.](/tables/cr1523-g008.jpg)
Figure 8. HR of myocardial infarction of GLP-1 RA versus comparators. GLP-1 RA: glucagon-like peptide 1 receptor agonist; HR: hazard ratio.
![Figure 9.](/tables/cr1523-g009.jpg)
Figure 9. HR of all-cause mortality of GLP-1 RA versus comparators. GLA: glargine; GLIM: glimepiride; GLP-1 RA: glucagon-like peptide 1 receptor agonist; HR: hazard ratio; LIR: liraglutide; SIT: sitagliptin.
![Figure 10.](/tables/cr1523-g010.jpg)
Figure 10. HR of CV death of GLP-1 RA versus comparators. CV: cardiovascular; GLA: glargine; GLIM: glimepiride; GLP-1 RA: glucagon-like peptide 1 receptor agonist; HR: hazard ratio; LIR: liraglutide; SIT: sitagliptin.